Company intelligence / Profile preview

DFB Soria

Fort Worth, Texas, United Statesdfbsoria.com ↗
Ownership
Private
Development stage
Other
01

Overview

The company completed a Phase II dose-escalation trial evaluating topical submicron particle paclitaxel ointment ("SOR007") for actinic keratosis. Results showed reduction in lesion size/count with minimal irritation or side effects. The product leverages a patented nanoparticle technology that increases surface area and allows better dermal penetration. The IP position is strong due to composition-of-matter patent protection through at least 2036. Further development options are being explored including potential partnerships or continued internal investment.

Therapeutic areas
OncologyDermatology
Modalities
Small moleculesTopical ointmentsNanoparticles
Industry
Biotech
02

Partnerships

Exclusive worldwide license from CritiTech, Inc. for nanoparticle production technology outside oncology fields.Affiliated with NanOlogy™, which develops similar technologies primarily focused on oncology indications.

Beyond the preview

Go deeper on DFB Soria.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

  • Partners
  • Deal terms
  • Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

  • Funding rounds
  • Investors
  • Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

  • Peer companies
  • Targets
  • Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

  • Platforms
  • Patents
  • Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

  • Company news
  • Sources
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on DFB Soria.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call